Company Filing History:
4 out of 4 
4 out of 38 
Years Active: 2008-2013
Title: George Jack: Innovator in Protective Antigen Research
Introduction
George Jack is a notable inventor based in Salisbury, GB. She has made significant contributions to the field of biotechnology, particularly in the development of protective antigens. With a total of 4 patents to her name, her work has had a substantial impact on vaccine development and public health.
Latest Patents
Among her latest patents is the "Preparation of Protective Antigen," which involves a polynucleotide sequence encoding recombinant Protective Antigen (rPA). This invention includes expression vectors and host cells that utilize the polynucleotide sequence, along with methods for producing rPA. This innovative approach is crucial for advancing vaccine technologies.
Career Highlights
George Jack has worked with prominent organizations such as Dynport Vaccine Company LLC and the Health Protection Agency. Her experience in these companies has allowed her to apply her research in practical settings, contributing to the development of effective health solutions.
Collaborations
Throughout her career, George has collaborated with esteemed colleagues, including Ian McEntee and Philip Vincent. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
George Jack's contributions to the field of protective antigens exemplify her dedication to advancing biotechnology. Her patents and collaborations reflect her commitment to improving public health through innovative research.